Pricing

Log inSign up

Vaxxas

0 followers

‌

Needle-free vaccination and vaccine delivery solutions that safely and cost effectively amplify vaccine efficacy using Nanopatch technology developed by Vaxxas.

Industries

Biotechnology, Health Care

Headquarters

Sydney, Australia

Employees

51-200

Links

Org chart

David Hoey
CEO
Collapse
Tom Lake
Chief Business Officer
Angus Forster
Chief Technology Officer
Michael Junger
Director - Industry And Government Relations
Charlotte Sweeney
Head of Formulation & Analytical
Deborah Pascoe, PhD
Senior Vice President, Pipeline Development
Doug Cubbin
Chief Financial Officer
SF
Scott Fry
Chief Operating Officer
Kevin Black, CPA, MBA
Head, Special Projects
ML
Michael Larcom
Senior Vice President of Quality

Board & advisors

Paul Kelly
Chairman
Sarah Meibusch
Board Observer and Alternate Director

Teams

+9

Research and Development

13 people · 0 jobs

+7

Medical Device Engineering

11 people · 0 jobs

+1

Management Team

5 people · 0 jobs

+1

Engineering Team

5 people · 0 jobs

SC

Project Management

4 people · 0 jobs

Leadership Team

3 people · 0 jobs

Offices

Similar companies

QuellTX

4 followers

Sutro Biopharma

3 followers

Active Motif

3 followers

Merck

277 followers

Dyno Therapeutics

4 followers

Cochlear

6 followers

Janux Therapeutics

1 follower

Prezzee

20 followers

Eikon Therapeutics

3 followers

PolyNovo Biomaterials

3 followers

Cosette Pharmaceuticals

1 follower

Explore companies